October 7, 2015
Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart "...



Patients who receive ALDACTAZIDE should be advised to avoid potassium supplements and foods containing high levels of potassium including salt substitutes.

Last reviewed on RxList: 3/21/2014
This monograph has been modified to include the generic and brand name in many instances.

Aldactazide - User Reviews

Aldactazide User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Aldactazide sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Heart Health

Get the latest treatment options.

Atrial Fibrillation Quiz